Trial Profile
The Effect Of Methylnaltrexone (Relistor) on Gut Motility and Tolerance to Tube Feeding in Patients Treated With Opiate Therapy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2015
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 20 Mar 2015 New trial record